How much revenue does Genesystem make?

Genesystem reported 381.36 million KRW in revenue for fiscal year 2025, down 68.4% from 1.21 billion KRW in fiscal year 2024.

Where does Genesystem make most of its revenue?

Asia: 78% of revenue by region in fiscal year 2024, followed by South Korea (16%).

What companies are similar to Genesystem?

Listed companies of a similar size in the same industry (DNA testing equipment) include Seegene, Inc. (096530.KQ), Genomictree Inc. (228760.KQ), Gencurix Inc. (229000.KQ), GeneMatrix Inc. (109820.KQ).

Genesystem Co., Ltd. (363250.KQ) Stock

About Genesystem Co., Ltd.

Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents. It also provides human pathogen assays, including novel coronavirus (SARS-CoV-2) detection kits, SARS-CoV-2/Flu/RSV simultaneous detection kits, and mycobacterium tuberculosis detection kits; veterinar...

At a glance

Genesystem reported revenue of 381.36 million KRW for fiscal year 2025, down 68.4% from fiscal year 2024, and net income of -11.96 billion KRW. Asia was its largest region in fiscal year 2024, with 78% of revenue.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.